By Greg Milano, CEO of Fortuna Advisors

Curing Corporate Short-Termism

Future Growth vs. Current Earnings

We are proud to showcase Curing Corporate Short-Termism by Fortuna Advisors’ CEO, Greg Milano. The book is an inside look at the ideas and applications that underpin much of Fortuna’s unique client work.

Buy on Amazon Watch Greg on Bloomberg

Also available in Hardcover and Kindle

Curing Corporate Short-Termism hardcover book by Gregory V. Milano

About the Book

Curing Corporate Short-Termism is a guide for senior managers who want to encourage more investment in the future of their companies, all while maintaining discipline around profitability and capital productivity.

Many corporate practices create stiff headwinds for managers trying to grow their business. The book explores the process of developing a “culture of ownership” that overcomes these obstacles, including prescriptive methods on how to better set goals, develop plans, allocate resources, approve investments, make operating decisions, measure performance, and design better incentive compensation.

Companies that embrace these principles produce long-term value that benefits not just the organization’s shareholders, but all of its many stakeholders, including society at large.

Related Media

Greg Milano interviewed on Bloomberg Television Watch on YouTube · 5:06

Bloomberg Television: Companies Have Invested Less Since the 1990s, Fortuna CEO Milano Says

Endorsements

An effective playbook for creating sustainable value that benefits all stakeholders.

Claus Aagaard

Chief Financial Officer, Mars, Inc.

As CEO of the first client to embrace the Fortuna Advisors framework, I can assure readers that their approach really works, and Curing Corporate Short-Termism is an interesting and engaging explanation of why and how to get managers to think more like owners of the company.

Bill Chiles

Board Member, Pelican Energy Partners (former CEO, Bristow Group)

Curing Corporate Short-Termism includes many of the steps we have taken by incorporating Varian Value Added, which is based on Fortuna’s RCE, into our way of bridging strategic planning to operating actions, capital allocation and performance measurement. This has helped transform our way of doing business. Our team is now living and breathing this as part of our business management system resulting in investing more in the future while driving current performance.

Gary E. Bischoping, Jr.

Senior Vice President Finance and Chief Financial Officer, Varian Medical Systems

… a must-read for executives, investors and boards. While the book may not eradicate corporate short-termism, it identifies the keys to long-term value creation and debunks the many myths, conventions and biases that stand in its way.

Scott Ostfeld

Partner and Co-Portfolio Manager, Jana Partners

… a thought-provoking book. This goes well beyond synthesizing the key elements of shareholder value creation and gets to the nub of the behavioral issues holding back optimal Intrinsic Value Creation. This will be certain to advance our thinking in corporate finance.

Paul Clancy

Executive Vice President and Chief Financial Officer, Alexion Pharmaceuticals

Inquiries

For inquiries related to the book, please reach out to:

in**@**************rs.com

Ready to

Learn More?

Connect with us to discuss your company and how we can find its catalyst for growth.

Start the Conversation